EGFR is one of the ErbB category of receptor tyrosine kinases and it is connected with worse prognosis in mind and throat squamous cell carcinoma (HNSCC). level 1 proof that cetuximab boosts overall success when coupled with cisplatinum and 5 FU. Pursuing progression on initial line chemotherapy many phase II studies claim that cetuximab monotherapy… Continue reading EGFR is one of the ErbB category of receptor tyrosine kinases